Frequency Therapeutics scores $42 mln Series B
Woburn, Massachusetts-based Frequency Therapeutics, a clinical-stage biotechnology company, has raised $42 million in Series B financing. Taiwania Capital Management and Axil Capital led the round with participation from Yonjin Capital, DF Investments, Polaris Founders Capital, Alexandria Venture Investments, CoBro Ventures, Korea Investment Partners and Emigrant Capital.
7 January 2019•1 min read
